The Indian Council of Medical Research (ICMR) has reported that 11.1% of 4.5 lakh patients tested through its Virus Research and Diagnostic Laboratories (VRDL) network in 2025 were found to have viral pathogens, indicating a rising trend in infectious diseases. The detection rate rose from 10.7% in the first quarter (Jan-Mar) to 11.5% in the second quarter (Apr-Jun), reports PTI. The top five pathogens identified were Influenza A in respiratory infections, dengue in fever cases, Hepatitis A in jaundice, Norovirus in diarrheal outbreaks, and Herpes simplex virus in encephalitis cases. The VRDL network, which expanded from 27 labs in 2014 to 165 labs across 31 states and UTs by 2025, acts as India's early warning system for infectious diseases. Between January and June, 580 disease clusters were investigated, including mumps, measles, rubella, chikungunya, and other viral infections. Since its inception, the network has tested over 40 lakh samples, identifying pathogens in 18.8% of them, and flagged 2,534 disease clusters nationwide. Experts warn that continuous surveillance is key to preventing future epidemics by timely detecting seasonal and emerging infections.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!